BR112017015789A2 - vacina de vírus da influenza suína bivalente - Google Patents
vacina de vírus da influenza suína bivalenteInfo
- Publication number
- BR112017015789A2 BR112017015789A2 BR112017015789A BR112017015789A BR112017015789A2 BR 112017015789 A2 BR112017015789 A2 BR 112017015789A2 BR 112017015789 A BR112017015789 A BR 112017015789A BR 112017015789 A BR112017015789 A BR 112017015789A BR 112017015789 A2 BR112017015789 A2 BR 112017015789A2
- Authority
- BR
- Brazil
- Prior art keywords
- swine influenza
- present
- bivalent
- influenza virus
- virus vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562121181P | 2015-02-26 | 2015-02-26 | |
PCT/US2016/019037 WO2016137929A1 (en) | 2015-02-26 | 2016-02-23 | Bivalent swine influenza virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017015789A2 true BR112017015789A2 (pt) | 2018-03-27 |
Family
ID=55487152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017015789A BR112017015789A2 (pt) | 2015-02-26 | 2016-02-23 | vacina de vírus da influenza suína bivalente |
Country Status (13)
Country | Link |
---|---|
US (2) | US10029005B2 (pt) |
EP (1) | EP3261664A1 (pt) |
JP (1) | JP6722686B2 (pt) |
KR (1) | KR20170122786A (pt) |
CN (1) | CN107250353B (pt) |
AU (1) | AU2016222962B2 (pt) |
BR (1) | BR112017015789A2 (pt) |
CL (2) | CL2017001961A1 (pt) |
EA (1) | EA201791907A1 (pt) |
MX (1) | MX2017010908A (pt) |
PH (1) | PH12017501370A1 (pt) |
TW (1) | TWI711462B (pt) |
WO (1) | WO2016137929A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2497492T3 (en) | 2004-06-01 | 2018-11-26 | Icahn School Med Mount Sinai | Genetically modified swine influenza virus and its applications |
MX2017010908A (es) | 2015-02-26 | 2017-12-07 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna bivalente contra el virus de gripe porcina. |
JP7346417B2 (ja) * | 2017-12-18 | 2023-09-19 | インターベット インターナショナル ベー. フェー. | ブタインフルエンザaウイルスワクチン |
MX2020006327A (es) * | 2017-12-20 | 2020-09-17 | Boehringer Ingelheim Vetmedica Gmbh | Deteccion de vacunas vivas modificadas contra el virus de la gripe porcina. |
BR112021005255A2 (pt) * | 2018-09-21 | 2021-06-29 | Board Of Regents Of The University Of Nebraska | método de produção e uso de genes para vacina contra a influenza centralizada universal |
US11696947B2 (en) * | 2018-10-31 | 2023-07-11 | Boehringer Ingelheim Vetmedica Gmbh | H52 IBV vaccine with heterologous spike protein |
AR116876A1 (es) * | 2018-10-31 | 2021-06-23 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna de ibv 4/91 con proteína espicular heteróloga |
MX2019014943A (es) * | 2018-12-12 | 2020-08-06 | Cambridge Tech Llc | Vacuna universal contra la gripe. |
US11642407B2 (en) * | 2020-02-28 | 2023-05-09 | Massachusetts Institute Of Technology | Identification of variable influenza residues and uses thereof |
CN113186173B (zh) * | 2021-04-15 | 2023-03-31 | 上海生物制品研究所有限责任公司 | 一种基于减毒流感病毒载体的新型冠状病毒肺炎疫苗 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US4071618A (en) | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
JPS57136528A (en) | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
JPS5939831A (ja) | 1982-08-27 | 1984-03-05 | Biseibutsu Kagaku Kenkyusho:Kk | 豚用インフルエンザウイルス不活化ワクチン |
US4693981A (en) | 1983-12-20 | 1987-09-15 | Advanced Genetics Research Institute | Preparation of inactivated viral vaccines |
US5106619A (en) | 1983-12-20 | 1992-04-21 | Diamond Scientific Co. | Preparation of inactivated viral vaccines |
JPS60202827A (ja) | 1984-03-28 | 1985-10-14 | Chibaken | 弱毒痘そうワクチン株 |
US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
US5840520A (en) | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
US5786199A (en) | 1989-08-28 | 1998-07-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US5766601A (en) | 1990-08-08 | 1998-06-16 | University Of Massachusetts Medical Center | Cross-reactive influenza a immunization |
US6162432A (en) | 1991-10-07 | 2000-12-19 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
AU677772B2 (en) | 1991-10-07 | 1997-05-08 | Biogen Idec Ma Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA -3 interaction |
DE69311764T2 (de) | 1992-05-14 | 1998-02-05 | Polymun Scient Immunbio Forsch | Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren |
US7344722B1 (en) | 1993-06-29 | 2008-03-18 | The Regents Of The University Of Michigan | Cold-adapted influenza virus |
ES2210273T5 (es) | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
US6300090B1 (en) | 1994-07-29 | 2001-10-09 | The Rockefeller University | Methods of use of viral vectors to deliver antigen to dendritic cells |
US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
DK0780475T4 (da) | 1995-08-09 | 2006-10-23 | Schweiz Serum & Impfinst | Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus |
US5840565A (en) | 1995-08-22 | 1998-11-24 | The Regents Of The University Of California | Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
CA2230033C (en) | 1995-09-27 | 2010-01-26 | Peter L. Collins | Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
ATE451451T1 (de) | 1996-07-15 | 2009-12-15 | Us Gov Health & Human Serv | Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen |
JP2000517194A (ja) | 1996-09-27 | 2000-12-26 | アメリカン・サイアナミド・カンパニー | モノネガビラレス(Mononegavirales)と称される目のウイルスにおける弱毒化の原因となる3’ゲノムプロモーター領域およびポリメラーゼ遺伝子の突然変異 |
JP2001514508A (ja) | 1997-03-05 | 2001-09-11 | ユニバーシティー オブ ワシントン | C型肝炎ウイルスの複製を選択的に抑制する薬剤を同定するための新規なスクリーニング法 |
US5891705A (en) | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
US6884414B1 (en) | 1997-04-30 | 2005-04-26 | Mount Sinai School Of Medicine Of New York University | Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents |
CN1250725C (zh) | 1997-05-23 | 2006-04-12 | 美国政府健康及人类服务部 | 从克隆的核苷酸序列制备减毒副流感病毒疫苗的方法 |
ATE361973T1 (de) | 1997-07-11 | 2007-06-15 | Univ Yale | Rhabdovirus mit gentechnisch veränderter hülle |
JP2001517448A (ja) | 1997-09-19 | 2001-10-09 | アメリカン・サイアナミド・カンパニー | 弱毒化呼吸合胞体ウイルス |
DE69937999T2 (de) | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
EP1085904B1 (en) | 1998-06-12 | 2012-11-28 | Mount Sinai School of Medicine | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
US6146642A (en) | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
AT407958B (de) | 1999-02-11 | 2001-07-25 | Immuno Ag | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation |
DE122007000061I2 (de) | 1999-07-14 | 2011-07-21 | Sinai School Medicine | In vitro-rekonstitution von segmentierten negativstrang-rna-viren. |
RU2280690C2 (ru) | 2000-03-02 | 2006-07-27 | Полимун Сайнтифик Иммунбиологише Форшунг Гмбх | Рекомбинантные вирусы гриппа а |
WO2001077394A1 (en) | 2000-04-10 | 2001-10-18 | Mount Sinai School Of Medicine Of New York University | Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents |
DE10020505A1 (de) | 2000-04-26 | 2001-10-31 | Conzelmann Karl Klaus | RSV NS Proteine antagonisieren die Interferon (IFN) Antwort |
US7494659B2 (en) | 2000-09-25 | 2009-02-24 | Polymun Scientific Immunbiologische Forschung Gmbh | Live attenuated influenza vaccine |
AU2003290842A1 (en) | 2002-11-13 | 2004-06-03 | Rutgers, The State University | Process for designing inhibitors of influenza virus non-structural protein 1 |
DK2497492T3 (en) | 2004-06-01 | 2018-11-26 | Icahn School Med Mount Sinai | Genetically modified swine influenza virus and its applications |
EP1855713B1 (en) | 2005-02-15 | 2016-04-27 | Mount Sinai School of Medicine | Genetically engineered equine influenza virus and uses thereof |
US20070116717A1 (en) | 2005-08-01 | 2007-05-24 | Shneider Alexander M | Influenza vaccine compositions and methods |
AT502275B8 (de) | 2005-08-08 | 2007-08-15 | Greenhills Biotechnology Res D | Immunantwort-induzierende zusammensetzungen |
CN101365479B (zh) | 2005-12-02 | 2013-06-26 | 纽约大学西奈山医学院 | 呈现非天然表面蛋白的嵌合病毒及其应用 |
US7507411B2 (en) | 2006-06-23 | 2009-03-24 | University Of Saskatchewan | Attenuated influenza NS1 variants |
WO2011014504A1 (en) | 2009-07-27 | 2011-02-03 | Mount Sinai School Of Medicine Of New York University | Recombinant influenza virus vectors and uses thereof |
CN102166352B (zh) * | 2011-04-13 | 2013-01-23 | 华威特(北京)生物科技有限公司 | 猪流感二价灭活疫苗的制备方法及其产品 |
US20130189303A1 (en) * | 2011-08-02 | 2013-07-25 | Yan Zhou | Recombinant swine influenza virus and uses thereof |
US9017694B2 (en) * | 2011-10-07 | 2015-04-28 | Medimmune, Llc | Swine influenza hemagglutinin variants |
CN103468647B (zh) * | 2013-09-03 | 2015-04-22 | 华中农业大学 | 猪流感h1n1和h3n2亚型的二价灭活疫苗 |
MX2017010908A (es) | 2015-02-26 | 2017-12-07 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna bivalente contra el virus de gripe porcina. |
-
2016
- 2016-02-23 MX MX2017010908A patent/MX2017010908A/es unknown
- 2016-02-23 BR BR112017015789A patent/BR112017015789A2/pt not_active IP Right Cessation
- 2016-02-23 JP JP2017545386A patent/JP6722686B2/ja not_active Expired - Fee Related
- 2016-02-23 AU AU2016222962A patent/AU2016222962B2/en not_active Ceased
- 2016-02-23 EP EP16708874.9A patent/EP3261664A1/en active Pending
- 2016-02-23 CN CN201680010359.4A patent/CN107250353B/zh active Active
- 2016-02-23 EA EA201791907A patent/EA201791907A1/ru unknown
- 2016-02-23 US US15/050,640 patent/US10029005B2/en active Active
- 2016-02-23 WO PCT/US2016/019037 patent/WO2016137929A1/en active Application Filing
- 2016-02-23 KR KR1020177027129A patent/KR20170122786A/ko unknown
- 2016-02-25 TW TW105105727A patent/TWI711462B/zh not_active IP Right Cessation
-
2017
- 2017-07-31 PH PH12017501370A patent/PH12017501370A1/en unknown
- 2017-08-01 CL CL2017001961A patent/CL2017001961A1/es unknown
-
2018
- 2018-06-22 US US16/015,512 patent/US10905756B2/en active Active
- 2018-09-24 CL CL2018002692A patent/CL2018002692A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2017001961A1 (es) | 2018-04-20 |
JP6722686B2 (ja) | 2020-07-15 |
US10029005B2 (en) | 2018-07-24 |
US20180289795A1 (en) | 2018-10-11 |
KR20170122786A (ko) | 2017-11-06 |
CN107250353A (zh) | 2017-10-13 |
EP3261664A1 (en) | 2018-01-03 |
TW201701900A (zh) | 2017-01-16 |
TWI711462B (zh) | 2020-12-01 |
PH12017501370A1 (en) | 2017-12-18 |
CN107250353B (zh) | 2021-07-23 |
WO2016137929A1 (en) | 2016-09-01 |
EA201791907A1 (ru) | 2018-02-28 |
AU2016222962B2 (en) | 2020-05-21 |
US10905756B2 (en) | 2021-02-02 |
AU2016222962A1 (en) | 2017-07-13 |
CL2018002692A1 (es) | 2019-01-18 |
US20160250318A1 (en) | 2016-09-01 |
JP2018512388A (ja) | 2018-05-17 |
MX2017010908A (es) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017015789A2 (pt) | vacina de vírus da influenza suína bivalente | |
BR112018013387A2 (pt) | vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit | |
BR112017009807A2 (pt) | métodos e formulações para tratamento de doenças oculares vasculares | |
BR112018076234A2 (pt) | vacina contra o vírus da bronquite infecciosa | |
BR112018012873A2 (pt) | vacina de vírus zika | |
BR112018075440A2 (pt) | composições e métodos para prevenir e tratar a infecção por zika vírus | |
BR112016003361A2 (pt) | vacina do vírus sincicial respiratório (rsv) | |
BR112016001192A2 (pt) | Vacina contra a raiva | |
BR112017001310A2 (pt) | coronavírus | |
BR112017020175A2 (pt) | composições adjuvantes e métodos relacionados | |
CL2019003805A1 (es) | Composiciones inmunógenas de senecavirus a y métodos de éstas. | |
BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
BR112015030229A2 (pt) | Partícula semelhante a vírus compreendendo um polipeptídeo e um antígeno da malária, vetor, composições farmacêutica e de vacina, bem como molécula de ácido nucleico isolado | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
BR112017019728A2 (pt) | combinações e formulações de dose fixa compreendendo etc1002 e uma ou mais estatinas e método para tratar ou reduzir o risco de doença cardiovascular | |
CL2019000722A1 (es) | Nueva vacuna contra la gripe porcina. | |
BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
BR112017004197A2 (pt) | composições de vacina contra doenças do vírus da dengue | |
BR112017019358A2 (pt) | combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular | |
BR112019009131A2 (pt) | vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas | |
BR112017006779A2 (pt) | composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento | |
PE20211095A1 (es) | Composiciones de escherichia coli y metodos de estas | |
BR112019006802A2 (pt) | compostos e métodos para diagnóstico e tratamento de infecções virais | |
BR112017028212A2 (pt) | vacinação concomitante contra dengue e febre amarela | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2711 DE 20-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |